Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Inflammatory Bowel Diseases

Free Subscription 24.06.2024 2 Aliment Pharmacol Ther 1 Am J Gastroenterol 2 BMC Gastroenterol 1 Clin Exp Immunol 2 Clin Gastroenterol Hepatol 4 Dig Dis Sci 1 Gastroenterology 1 Inflamm Bowel Dis 5 J Crohns Colitis 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. BAK MTJ, Demers K, Hammoudi N, Allez M, et al
   Systematic review: Patient-related, microbial, surgical, and histopathological risk factors for endoscopic post-operative recurrence in patients with Crohn's disease.
   Aliment Pharmacol Ther. 2024 Jun 17. doi: 10.1111/apt.18040.
   PubMed         Abstract available
   
   
2. CHHIBBA T
   Editorial: Surgery to reduce opioid use in Crohn's disease: Does a classic solution address a newer problem?
   Aliment Pharmacol Ther. 2024 Jun 14. doi: 10.1111/apt.18051.
   PubMed        
   
   

   
   Am J Gastroenterol

3. BARNES EL, Desai A, Hashash JG, Farraye FA, et al
   The Natural History after Ileal Pouch-Anal Anastomosis for Ulcerative Colitis: A Population-Based Cohort Study from the United States.
   Am J Gastroenterol. 2024 Jun 18. doi: 10.14309/ajg.0000000000002891.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

4. WANG T, Sun H, Zhang M, Shen P, et al
   B3GNT7 regulates mucin O-glycosylation to alleviate colonic inflammation.
   BMC Gastroenterol. 2024;24:202.
   PubMed         Abstract available
   
   
5. ZHANG L, Shen P, Ge W, Liao W, et al
   Mediating role of chiro-inositol metabolites on the effects of HLA-DR-expressing CD14 + monocytes in inflammatory bowel disease.
   BMC Gastroenterol. 2024;24:200.
   PubMed         Abstract available
   
   

   
   Clin Exp Immunol

6. FANG M, Yao J, Zhang H, Sun J, et al
   Specific deletion of Mettl3 in IECs triggers the development of spontaneous colitis and dysbiosis of T lymphocytes in mice.
   Clin Exp Immunol. 2024;217:57-77.
   PubMed         Abstract available
   
   

   
   Clin Gastroenterol Hepatol

7. TORRES J, Mahadevan U
   Editorial: Ustekinumab and Vedolizumab Safety and Clearance in Pregnancy with Inflammatory Bowel Disease: Stop the Disease, not the Drug!
   Clin Gastroenterol Hepatol. 2024 Jun 13:S1542-3565(24)00543.
   PubMed        
   
   
8. MAHMUD O, Fatimi AS, Mahar MU, Jahangir A, et al
   Sphingosine 1-Phosphate Receptor Modulators are Effective in Patients With Moderately to Severely Active Ulcerative Colitis and a Prior Biologic Exposure: A Meta-Analysis of Randomized Controlled Trials.
   Clin Gastroenterol Hepatol. 2024;22:1139-1141.
   PubMed        
   
   

   
   Dig Dis Sci

9. AGRAWAL G, Borody TJ, Aitken JM
   Mapping Crohn's Disease Pathogenesis with Mycobacterium paratuberculosis: A Hijacking by a Stealth Pathogen.
   Dig Dis Sci. 2024 Jun 19. doi: 10.1007/s10620-024-08508.
   PubMed         Abstract available
   
   
10. LOWELL JA, Sharma G, Chua V, Ben-Horin S, et al
    Reactive Immunomodulator Addition to Infliximab Monotherapy Restores Clinical Response in Inflammatory Bowel Disease: A Meta-Analysis.
    Dig Dis Sci. 2024 Jun 14. doi: 10.1007/s10620-024-08515.
    PubMed         Abstract available
    
    
11. TE VELDE AA
    Putting Crohn's Disease on the MAP: Potential Contribution of a "Stealth Pathogen".
    Dig Dis Sci. 2024 Jun 20. doi: 10.1007/s10620-024-08503.
    PubMed        
    
    
12. ALIZADEH M, Wong U, Siaton BC, Patil SA, et al
    Inflammatory Bowel Disease-Associated Arthritis Is Associated with Concomitant Autoimmune and Inflammatory Disorders.
    Dig Dis Sci. 2024 Jun 20. doi: 10.1007/s10620-024-08478.
    PubMed         Abstract available
    
    

    
    Gastroenterology

13. ZINGONE F, Bai JC, Cellier C, Ludvigsson JF, et al
    Celiac disease-related conditions: Who to test?
    Gastroenterology. 2024 Mar 7:S0016-5085(24)00282.
    PubMed         Abstract available
    
    

    
    Inflamm Bowel Dis

14. SAFRONEEVA E, Thorne H, Gerstner O, Laoun R, et al
    Similar Efficacy of Mesalazine in Adult and Older Adult Ulcerative Colitis Patients: Post Hoc Analysis of a Randomized Noninferiority Trial of 1600 mg vs 400 mg Tablets.
    Inflamm Bowel Dis. 2024 Jun 21:izae123. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Crohns Colitis

15. PROSBERG MV, Halkjaer SI, Lo B, Bremerskov-Koser C, et al
    Probiotic Treatment of Ulcerative Colitis with Trichuris suis ova: A Randomized, Double-blinded, Placebo-controlled Clinical Trial (the PROCTO Trial).
    J Crohns Colitis. 2024 Jun 20:jjae095. doi: 10.1093.
    PubMed         Abstract available
    
    
16. MUNDHRA SK, Madan D, Golla R, Sahu P, et al
    Intravenous albumin infusion does not augment the response rate to a combination of exclusive enteral nutrition and intravenous steroids in acute severe ulcerative colitis: a randomized controlled trial.
    J Crohns Colitis. 2024 Jun 17:jjae094. doi: 10.1093.
    PubMed         Abstract available
    
    
17. KELM M, Wagner L, Widder A, Pistorius R, et al
    Perioperative Enhanced Recovery Concepts Significantly Improve Postoperative Outcome in Patients with Crohn;s Disease.
    J Crohns Colitis. 2024 Jun 15:jjae090. doi: 10.1093.
    PubMed         Abstract available
    
    
18. ADAMINA M, Minozzi S, Warusavitarne J, Buskens C, et al
    ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment.
    J Crohns Colitis. 2024 Jun 15:jjae089. doi: 10.1093.
    PubMed         Abstract available
    
    
19. GORDON H, Minozzi S, Kopylov U, Verstockt B, et al
    ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment.
    J Crohns Colitis. 2024 Jun 15:jjae091. doi: 10.1093.
    PubMed        
    
    

    
    PLoS One

20. ZHANG K, Nakaoka S
    An energy landscape approach reveals the potential key bacteria contributing to the development of inflammatory bowel disease.
    PLoS One. 2024;19:e0302151.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.